Search
Resmed Inc
RMDAdd to Watchlist
196.340USD
+5.080+2.66%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
28.50BMarket Cap
18.86P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+2.66%
5 Days
+5.39%
1 Month
-5.63%
6 Months
-19.68%
Year to Date
-18.49%
1 Year
-23.28%
Key Figures
192.910Open
197.600High
1.67MVolume
18.86P/E TTM
16.25P/E Dynamic
2.330Dividend TTM
1.14%Turnover Ratio
191.260Prev. Close
192.355Low
180.72MTurnover
20.46P/E Static
4.68P/B
1.19%Div Yield TTM
18.59%ROA
293.81052wk High
0.90Volume Ratio
1.40BNet Profit
145.94MShares
10.4102EPS TTM
0.83Beta
25.25%ROE
198.61052wk Low
2.74%Amplitude
61.46%Gross Margin
28.50BMarket Cap
-5.83Reward/Risk
1.38%Risk Rate
TradingKey Stock Score of Resmed Inc
Currency: USD Updated: 2026-06-24Key Insights
Resmed Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 260.63.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Resmed Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative-
Resmed Inc Highlights
StrengthsRisks
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 21.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.15B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.19%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.19%.
Undervalued
The company’s latest PE is 18.88, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 100.10M shares, decreasing 1.39% quarter-over-quarter.
Held by Ray Dalio
Star Investor Ray Dalio holds 42.60K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.55.
Analyst Rating
Based on
21
analysts
Buy
Current Rating
260.634
Target Price
+38.17%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Resmed Inc Info
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Ticker SymbolRMD
CompanyResmed Inc
CEOFarrell (Michael J)
Websitehttps://www.resmed.com/
Related Instruments
-0.81%
+4.88%
-0.02%
-0.33%
+5.54%
+0.40%
+1.21%
-0.55%
+0.25%
-2.83%
-1.30%
-2.50%
+1.22%
+3.11%
+2.12%
+0.79%
+1.45%
+2.69%
+10.74%
+3.89%Popular Instruments
51832.400
-139.300 (-0.27%)
29719.900
-74.300 (-0.25%)
7395.900
-14.500 (-0.20%)
15794.000
+257.000 (+1.65%)
71834.000
+877.000 (+1.24%)
6217.800
-10.400 (-0.17%)
69.374
-0.385 (-0.55%)
293.080
-1.220 (-0.41%)
199.000
-1.040 (-0.52%)
3989.560
-9.180 (-0.23%)
FAQs
What is the current price of Resmed Inc (RMD)?
The current price of Resmed Inc (RMD) is 196.34.
What is the symbol of Resmed Inc?
The ticker symbol of Resmed Inc is RMD.
What is the 52-week high of Resmed Inc?
The 52-week high of Resmed Inc is 293.81.
What is the 52-week low of Resmed Inc?
The 52-week low of Resmed Inc is 198.61.
What is the market capitalization of Resmed Inc?
The market capitalization of Resmed Inc is 28.65B.
Is Resmed Inc (RMD) currently rated as Buy, Hold, or Sell?
According to analysts, Resmed Inc (RMD) has an overall rating of Buy, with a price target of 260.63.
What is the Earnings Per Share (EPS TTM) of Resmed Inc (RMD)?
The Earnings Per Share (EPS TTM) of Resmed Inc (RMD) is 9.55.
